Surgery Partners (SGRY) Stock Price Down 5.3%
Surgery Partners Inc (NASDAQ:SGRY)’s share price fell 5.3% on Thursday . The stock traded as low as $14.25 and last traded at $14.30. 728,076 shares changed hands during mid-day trading, an increase of 59% from the average session volume of 457,721 shares. The stock had previously closed at $15.10.
Several research firms recently commented on SGRY. Zacks Investment Research lowered Surgery Partners from a “hold” rating to a “sell” rating in a research report on Tuesday. Benchmark set a $19.00 price target on Surgery Partners and gave the stock a “buy” rating in a research report on Tuesday, January 30th. ValuEngine lowered Surgery Partners from a “hold” rating to a “sell” rating in a research report on Friday, February 2nd. Jefferies Group reduced their price target on Surgery Partners from $16.00 to $13.00 and set a “buy” rating on the stock in a research report on Wednesday, November 1st. Finally, BidaskClub raised Surgery Partners from a “sell” rating to a “hold” rating in a research report on Wednesday, December 27th. Three analysts have rated the stock with a sell rating, four have given a hold rating and four have issued a buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $17.86.
The stock has a market cap of $736.42 and a PE ratio of -158.89. The company has a debt-to-equity ratio of 1.56, a current ratio of 2.09 and a quick ratio of 1.92.
Surgery Partners declared that its Board of Directors has initiated a share buyback plan on Friday, December 15th that allows the company to repurchase $50.00 million in outstanding shares. This repurchase authorization allows the company to repurchase shares of its stock through open market purchases. Shares repurchase plans are often an indication that the company’s leadership believes its stock is undervalued.
Several institutional investors and hedge funds have recently made changes to their positions in the business. Bain Capital Investors LLC acquired a new position in shares of Surgery Partners in the 3rd quarter valued at approximately $273,816,000. Vanguard Group Inc. raised its position in shares of Surgery Partners by 5.6% in the 2nd quarter. Vanguard Group Inc. now owns 1,595,966 shares of the company’s stock valued at $36,309,000 after purchasing an additional 85,148 shares in the last quarter. Royce & Associates LP raised its position in shares of Surgery Partners by 160.0% in the 3rd quarter. Royce & Associates LP now owns 681,582 shares of the company’s stock valued at $7,054,000 after purchasing an additional 419,457 shares in the last quarter. JPMorgan Chase & Co. raised its position in shares of Surgery Partners by 156.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 524,775 shares of the company’s stock valued at $5,379,000 after purchasing an additional 319,775 shares in the last quarter. Finally, Elk Creek Partners LLC raised its position in shares of Surgery Partners by 6.9% in the 3rd quarter. Elk Creek Partners LLC now owns 464,829 shares of the company’s stock valued at $4,811,000 after purchasing an additional 30,172 shares in the last quarter. 94.03% of the stock is currently owned by institutional investors.
About Surgery Partners
Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.